Collaboration brings whole-exome based hereditary cancer insights to urologists and their patients by offering it alongside Veracyte's Decipher Prostate Test SAN MATEO, Calif., Aug. 7, 2025 ...
OncoHelix will now offer the validated ClarityDX Prostate Risk Score to healthcare providers and their patients suspected of having aggressive prostate cancer. ClarityDX Prostate is a blood-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback